NMTC
Neuroone Medical Technologies Corp
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
—
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Neuroone Medical Technologies Corp
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
—
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
0.00%
NMTC weight · VTI
No changes.
No changes.
| Manager | Value | % base | |
|---|---|---|---|
| Princeton Global | $8,527 | 99.79% | −83.34% |
| Quent Capital | $18 | 0.21% | −85.00% |
| Manager | Value | % base | |
|---|---|---|---|
| Princeton Global | $8,527 | 99.79% | −83.34% |
| Quent Capital | $18 | 0.21% | −85.00% |
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; no measured co-movers for Neuroone Medical Technologies Corp.
Same SIC code · 6
Same SEC industry code: Stryker Corp, 3M Co, Boston Scientific Corp and 3 more; no measured co-movers for Neuroone Medical Technologies Corp.
Annual filing, covered
10-K parsed · Dec 17 '25
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
Annual filing, covered
10-K parsed · Dec 17 '25
Supply-chain ties, covered
Disclosed · both directions
Fund holders, covered
N-PORT holdings
13F holdings, covered
13F quarter · Jun 30 '26
Management, not covered
Not covered · DEF 14A, 8-K 5.02
Company IR feed, not covered
News via newswires & EDGAR
Products, patents, hiring, not covered
Not covered
No thesis.
Neuroone Medical Technologies Corp
0.94
+0.01 · +0.56%
post 0.96 +2.13%
No trades yet today.
No trades yet today.
Largest filed tie
—
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator for use with NeuroOne's combination recording and ablation electrode to record brain activity and ablate brain tissue using the same electrode. The company is based in Eden Prairie, Minnesota.
Tall tick = annual report · Source: EDGAR
—
—
Expected move
No implied move.